Figure 4
![Figure 4. Effect of treatment on late bacterial infection. Treatment effect estimated from Cox model adjusted for disease status and stem-cell source (HR [ATG-F vs control]= 0.68, 95% CI, 0.39-1.17, P = .16).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/117/23/10.1182_blood-2011-01-329821/4/zh89991171840004.jpeg?Expires=1722708334&Signature=1clhCCKaX~NJ7sclW4-Zukyk~2uYDKkhg89FsccdTEh0pDwvFmoRdb2008aYmxu-I2zsQEZo5EVEFQrr2PTaK8CNgh7eRePXIqlNIO0RULaWjaUB1~vz5kjwUnKFvc6vSo1OYEK9acYBKy8aj6IqeZVzt2uoFiKAsgEDI~khkKgUJMPKRu0kdVHmY4MiUYE3K~aDnIX4le2VPaiLZEC9VGDKGg232mmXlTxHMJqiBAD4OtHbHgCfCPJIUpOGd65hZpeLId~zeINnGWtb~Eohbp~VF2KhVOX-TIwRvNKIcv6dwIqYAfmK9TnuBBX6znR3u7bm1Z5Z5QUOoUh02GmEuQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Effect of treatment on late bacterial infection. Treatment effect estimated from Cox model adjusted for disease status and stem-cell source (HR [ATG-F vs control]= 0.68, 95% CI, 0.39-1.17, P = .16).
Effect of treatment on late bacterial infection. Treatment effect estimated from Cox model adjusted for disease status and stem-cell source (HR [ATG-F vs control]= 0.68, 95% CI, 0.39-1.17, P = .16).
